Data / Form D filings / Amprion, Inc.
Amprion, Inc.: Form D filings
Amprion, Inc., a biotechnology company in San Francisco, CA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on September 27, 2024, reports $5.8 million sold of a $15 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 149 NEW MONTGOMERY STREET, 4TH FLOOR, San Francisco, CA, 94105
- Phone
- (281) 802-4776
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1937140
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | Amendment | $15,000,000 | $5,761,371 | $9,238,629 | 7 | Sep 10, 2024 | sec.gov |
| Sep 25, 2024 | New notice | $15,000,000 | $3,761,381 | $11,238,619 | 6 | Sep 10, 2024 | sec.gov |
| Jul 15, 2022 | New notice | $10,956,960 | $10,956,960 | 9 | Jun 24, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marc Chan | Director | |
| Russell Lebovitz | Executive Officer, Director | |
| Rahul Bhansali | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 23, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Amprion, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.